Free Trial

The Pennant Group (NASDAQ:PNTG) Shares Down 3.3%

→ Next President (Not Trump. Not Biden.) (From The Freeport Society) (Ad)

The Pennant Group, Inc. (NASDAQ:PNTG - Get Free Report) dropped 3.3% during mid-day trading on Tuesday . The company traded as low as $22.50 and last traded at $22.62. Approximately 163,154 shares traded hands during mid-day trading, an increase of 8% from the average daily volume of 150,378 shares. The stock had previously closed at $23.39.

Analysts Set New Price Targets

Several research firms recently weighed in on PNTG. Stephens reaffirmed an "overweight" rating and set a $23.00 target price on shares of The Pennant Group in a research note on Tuesday, May 7th. Royal Bank of Canada raised their target price on shares of The Pennant Group from $21.00 to $26.00 and gave the company an "outperform" rating in a research note on Thursday, May 9th. Truist Financial lifted their price objective on shares of The Pennant Group from $16.00 to $21.00 and gave the company a "hold" rating in a report on Friday, March 1st. Finally, Oppenheimer lifted their price objective on shares of The Pennant Group from $18.00 to $22.00 and gave the company an "outperform" rating in a research note on Friday, March 1st.

View Our Latest Report on The Pennant Group

The Pennant Group Trading Down 5.0 %

The stock has a market capitalization of $667.41 million, a PE ratio of 42.07, a PEG ratio of 2.39 and a beta of 2.01. The business's 50-day moving average is $20.22 and its two-hundred day moving average is $16.51. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.51.


The Pennant Group (NASDAQ:PNTG - Get Free Report) last released its earnings results on Wednesday, February 28th. The company reported $0.18 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.19 by ($0.01). The Pennant Group had a net margin of 2.86% and a return on equity of 13.42%. The company had revenue of $145.95 million during the quarter, compared to analyst estimates of $136.79 million. During the same period in the previous year, the firm posted $0.15 EPS. On average, analysts anticipate that The Pennant Group, Inc. will post 0.73 earnings per share for the current fiscal year.

Hedge Funds Weigh In On The Pennant Group

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Boston Partners lifted its position in shares of The Pennant Group by 26.0% in the third quarter. Boston Partners now owns 212,897 shares of the company's stock valued at $2,369,000 after acquiring an additional 43,978 shares in the last quarter. Vanguard Group Inc. lifted its position in The Pennant Group by 0.8% during the 3rd quarter. Vanguard Group Inc. now owns 1,693,196 shares of the company's stock worth $18,845,000 after acquiring an additional 14,138 shares in the last quarter. First Eagle Investment Management LLC raised its position in shares of The Pennant Group by 16.7% in the 3rd quarter. First Eagle Investment Management LLC now owns 397,900 shares of the company's stock valued at $4,429,000 after purchasing an additional 56,893 shares in the last quarter. Paradigm Capital Management Inc. NY increased its holdings in shares of The Pennant Group by 79.1% in the 3rd quarter. Paradigm Capital Management Inc. NY now owns 1,196,500 shares of the company's stock valued at $13,317,000 after acquiring an additional 528,612 shares during the last quarter. Finally, Kent Lake Capital LLC grew its stake in The Pennant Group by 34.6% during the 3rd quarter. Kent Lake Capital LLC now owns 583,631 shares of the company's stock worth $6,496,000 after buying an additional 150,187 shares during the last quarter. 85.88% of the stock is currently owned by hedge funds and other institutional investors.

The Pennant Group Company Profile

(Get Free Report)

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ Obama’s Forever Term [exposed] (From Porter & Company) (Ad)

Should you invest $1,000 in The Pennant Group right now?

Before you consider The Pennant Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Pennant Group wasn't on the list.

While The Pennant Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Featured Articles and Offers

Search Headlines: